Literature DB >> 15157688

Modulation of morphine analgesia by site-specific N-methyl-D-aspartate receptor antagonists: dependence on sex, site of antagonism, morphine dose, and time.

Kumar V S Nemmani1, Judith E Grisel, Jennifer R Stowe, Richard Smith-Carliss, Jeffrey S Mogil.   

Abstract

Pharmacological blockade of N-methyl-D-aspartate (NMDA) receptors can modulate morphine analgesia in experimental animals and humans. However, this literature is highly inconsistent, with NMDA receptor antagonists variously shown to potentiate, attenuate or produce no effect on morphine analgesic magnitude. A number of factors influencing this modulation have been proposed, but no one has examined such factors simultaneously, and all existing studies in mice were conducted exclusively in male subjects. Thus, the influence of systemic administration of site-specific NMDA receptor antagonists-including dextromethorphan, dextrorphan, MK-801, LY235959, L-701,324, and Ro 25-6981-on morphine analgesia (15-45 mg/kg; 15, 30 and 60 min post-injection) was studied in male and female mice using the 49 degrees C tail-withdrawal test. We found that oral and intraperitoneal dextromethorphan, a low-affinity non-competitive antagonist, dose-dependently potentiated low-dose morphine analgesia but attenuated high-dose morphine analgesia. Dextrorphan and MK-801 were found to potentiate low- but not high-dose morphine analgesia. The competitive glutamate-site antagonist, LY235959, and glycine-site antagonist, L-701,324, potentiated morphine analgesia at all doses. In contrast, the polyamine (NR2B) site antagonist, Ro 25-6981, attenuated morphine analgesia at all doses. Strikingly, the non-competitive antagonists produced no modulation of morphine analgesia whatsoever in female mice, whereas no sex differences were observed using competitive or NR2B antagonists. These findings indicate that NMDA modulation of morphine analgesia is critically influenced by sex, site of antagonism, morphine dose and time after injection. Our data suggest that NMDA antagonism via competitive or glycine site antagonism might result in more reliable clinical effects on morphine analgesia in both sexes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15157688     DOI: 10.1016/j.pain.2004.01.035

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  23 in total

1.  Evaluation of morphine analgesia and motor coordination in mice following cortex-specific knockout of the N-methyl-D-aspartate NR1-subunit.

Authors:  Gabriel C Quintero; Reha S Erzurumlu; Anthony L Vaccarino
Journal:  Neurosci Lett       Date:  2008-03-30       Impact factor: 3.046

2.  μ-Opioid Receptor Gene A118 G Variants and Persistent Pain Symptoms Among Men and Women Experiencing Motor Vehicle Collision.

Authors:  Sarah D Linnstaedt; JunMei Hu; Andrey V Bortsov; April C Soward; Robert Swor; Jeffrey Jones; David Lee; David Peak; Robert Domeier; Niels Rathlev; Phyllis Hendry; Samuel A McLean
Journal:  J Pain       Date:  2015-04-02       Impact factor: 5.820

3.  Differences in carbachol dose, pain condition, and sex following lateral hypothalamic stimulation.

Authors:  J E Holden; E Wang; J R Moes; M Wagner; A Maduko; Y Jeong
Journal:  Neuroscience       Date:  2014-04-20       Impact factor: 3.590

4.  Contribution of opioid and metabotropic glutamate receptor mechanisms to inhibition of bladder overactivity by tibial nerve stimulation.

Authors:  Yosuke Matsuta; Abhijith D Mally; Fan Zhang; Bing Shen; Jicheng Wang; James R Roppolo; William C de Groat; Changfeng Tai
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-04-10       Impact factor: 3.619

Review 5.  Sex differences in innate immunity and its impact on opioid pharmacology.

Authors:  Hillary H Doyle; Anne Z Murphy
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

6.  Sex-specific mediation of opioid-induced hyperalgesia by the melanocortin-1 receptor.

Authors:  Aaron Juni; Minying Cai; Magda Stankova; Amanda R Waxman; Caroline Arout; Gad Klein; Albert Dahan; Victor J Hruby; Jeffrey S Mogil; Benjamin Kest
Journal:  Anesthesiology       Date:  2010-01       Impact factor: 7.892

Review 7.  Sex differences in pain and pain inhibition: multiple explanations of a controversial phenomenon.

Authors:  Jeffrey S Mogil
Journal:  Nat Rev Neurosci       Date:  2012-12       Impact factor: 34.870

8.  Opioid antinociception, tolerance and dependence: interactions with the N-methyl-D-aspartate system in mice.

Authors:  Linda A Dykstra; Bradford D Fischer; Rebecca E Balter; Fredrick E Henry; Karl T Schmidt; Laurence L Miller
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

9.  Adolescent opioid exposure in female rats: transgenerational effects on morphine analgesia and anxiety-like behavior in adult offspring.

Authors:  John J Byrnes; Jessica A Babb; Victoria F Scanlan; Elizabeth M Byrnes
Journal:  Behav Brain Res       Date:  2010-12-05       Impact factor: 3.332

10.  Patient characteristics affect the response to ketamine and opioids during the treatment of vaso-occlusive episode-related pain in sickle cell disease.

Authors:  Raissa Nobrega; Kathy A Sheehy; Caroline Lippold; Amy L Rice; Julia C Finkel; Zenaide M N Quezado
Journal:  Pediatr Res       Date:  2017-09-13       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.